Headlines

FDA Approves AstraZeneca’s Calquence Combo Therapy For Untreated Mantle Cell Lymphoma

AstraZeneca’s Calquence gains FDA approval for untreated mantle cell lymphoma, supported by data showing improved survival and reduced disease progression.

read more

Join the newsletter

Subscribe to get our latest content by email.

    We respect your privacy. Unsubscribe at any time.

    Leave a Reply

    Your email address will not be published. Required fields are marked *